Characterization of ST11 and ST15 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae from Patients with Ventilator-Associated Pneumonia
Shuang Song,Shulong Zhao,Wei Wang,Fei Jiang,Jingfang Sun,Ping Ma,Haiquan Kang
DOI: https://doi.org/10.2147/IDR.S426901
2023-09-09
Infection and Drug Resistance
Abstract:Shuang Song, 1, 2, &ast Shulong Zhao, 2, &ast Wei Wang, 1 Fei Jiang, 2 Jingfang Sun, 2 Ping Ma, 1, 2 Haiquan Kang 2 1 Medical Technology School, Xuzhou Medical University, Xuzhou, People's Republic of China; 2 Department of Clinical Laboratory, Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haiquan Kang, Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People's Republic of China, Tel +86-516 85802759, Email Ping Ma, Medical Technology School, Xuzhou Medical University, Department of Laboratory Medicine, Xuzhou, People's Republic of China, Tel +86-516 85807017, Email Background: The prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (hv-CRKP) is a serious public threat globally. Here, we performed clinical, molecular, and phenotypic monitoring of hv-CRKP strains isolated from the intensive care unit (ICU) to offer evidence for prevention and control in hospitals. Methods: Data analysis of ICU patients suffering from ventilator-associated pneumonia (VAP) because of hv-CRKP infection, admitted at the Chinese Teaching Hospital between March 2019 and September 2021 was performed. Patients' antibiotic-resistance genes, virulence-associated genes, and capsular serotypes of these isolates were detected. Homology analysis of the strains was performed by MLST and PFGE. Six different strains were tested for their virulence traits using the serum killing test and the Galleria mellonella infection assay. For whole genome sequencing, KP3 was selected as a representative strain. Results: Clinical data of 19 hv-CRKP-VAP patients were collected and their hv-CRKP were isolated, including 10 of ST11-KL64, 4 of ST15-KL112, 2 of ST11-KL47, 1 of ST15-KL19, 1 of ST17-KL140, and 1 of ST48-KL62. Four ST15 and 8 ST11 isolates revealed high homology, respectively. Most strains carried the carbapenemase gene bla KPC-2 (14/19, 73.68%), followed by bla OXA-232 (4/19, 21.05%). All strains were resistant to almost all the antibiotics except polymyxin and tigacycline. Ten patients were treated with polymyxin or tigacycline based on their susceptibility results, and unfortunately 6 patients died. All strains exhibited a hyper-viscous phenotype, and the majority (17/19, 89.47%) of them contained rmpA and rmpA2 . The serum killing test showed that KP9 was resistant to normal healthy serum, others were intermediately or highly sensitive. G. mellonella larvae infection assay suggested that the strains in this study were hypervirulent. Conclusion: This study highlights the dominant strain and molecular epidemiology of hv-CRKP in a hospital in China. We should pay more attention to the effect of hv-CRKP on VAP, strengthen monitoring and control transmission. Keywords: Klebsiella pneumoniae , hypervirulent, carbapenem-resistant, ventilator-associated pneumonia Klebsiella pneumoniae is a gram-negative opportunistic pathogen that can cause both community and hospital-acquired pneumonia, urinary tract infections, and bacteremia primarily in immunocompromised patients. 1 Most experts agree that carbapenems are an effective treatment for serious infections brought on by Enterobacteriaceae that produce extended-spectrum beta-lactamases (ESBLs). 2–4 Because of the wide and irrational use of antibiotics, the number of carbapenemase-resistant Enterobacteriaceae (CRE) infections is increasing per year and antibiotic resistance has become an international problem. 5,6 During 2005–2020, the China Antimicrobial Surveillance Network (CHINET, http://www.chinets.com ) reported that K. pneumoniae resistance rates to imipenem and meropenem have rapidly increased from 3% and 2.9% to 23.2% and 24.2% respectively. There has been a significant increase in respiratory tract infections in intensive care units (ICUs) due to carbapenem-resistant K. pneumoniae (CRKP), which is considered a severe danger to public health as a pathogen associated with hospital-acquired infections (HAIs). 7–10 It is reported that 9–27% of ICU patients suffer from ventilator-associated pneumonia (VAP). 11 Meanwhile, treatment of CRKP-induced VAP in ICU patients is difficult because of the lack of multiple therapeutic drugs. Hypervirulent K. pneumoniae (hvKP) is the primary cause of community-acquired illnesses such as meningitis, necrotizing fasciitis, endophthalmitis, liver absce -Abstract Truncated-
pharmacology & pharmacy,infectious diseases